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TelencephalonThis work was designed to determine the role of the vascular endothelial growth factor A (VEGF) isoforms
during early neuroepithelial development in the mammalian central nervous system (CNS), speciﬁcally in
the forebrain. An emerging model of interdependence between neural and vascular systems includes VEGF,
with its dual roles as a potent angiogenesis factor and neural regulator. Although a number of studies have
implicated VEGF in CNS development, little is known about the role that the different VEGF isoforms play
in early neurogenesis. We used a mouse model of disrupted VEGF isoform expression that eliminates
the predominant brain isoform, VEGF164, and expresses only the diffusible form, VEGF120. We tested the
hypothesis that VEGF164 plays a key role in controlling neural precursor populations in developing cortex.
We usedmicroarray analysis to compare gene expression differences betweenwild type and VEGF120mice at
E9.5, the primitive stem cell stage of the neuroepithelium. We quantiﬁed changes in PHH3-positive nuclei,
neural stem cell markers (Pax6 and nestin) and the Tbr2-positive intermediate progenitors at E11.5 when the
neural precursor population is expanding rapidly. Absence of VEGF164 (and VEGF188) leads to reduced
proliferation without an apparent effect on the number of Tbr2-positive cells. There is a corresponding
reduction in the number of mitotic spindles that are oriented parallel to the ventricular surface relative to
those with a vertical or oblique angle. These results support a role for the VEGF isoforms in supporting the
neural precursor population of the early neuroepithelium.ta, Biology Department, 9019,
arland).
Neurobiology, University of
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Key issues in early central nervous system (CNS) development
concern how neural stem cell populations contribute to the developing
brain and the heterotypic cell–cell interactions that regulate the
differentiation and survival processes. Neurogenesis, the formation of
new neurons, requires the orchestration of neural stem cell prolifera-
tion, initiation of differentiation, and pathway-appropriate neuronal
migration and connectivity (reviewed in Nicholls et al., 2001). The
coordination of these processes is particularly important in the
mammalian cerebrumwhere precise temporal and spatial organizationduring development yields the characteristic layering of the cortex
(reviewed in Brazel et al., 2003; Fishell and Kriegstein, 2003; Göetz and
Sommer, 2005; Mori et al., 2005). Recent evidence has highlighted
several transcription factors, including Pax6, Tbr2, neurogenin 2, and
Tbr1, that function to sequentially restrict stem cells as they move
toward speciﬁc fates in the cortex (reviewed in Hevner et al., 2006).
Moreover, several signaling pathways, notably notch (Kawaguchi et al.,
2008; Mizutani et al., 2007; Shen et al., 2002; Shimojo et al., 2008) and
EGF (Sun et al., 2005), have been implicated in cell fate decisions in the
CNS partly due to their differential effects on symmetrical versus
asymmetrical divisions of neural precursor cells at the ventricular zone.
Neural stem cells give rise to the majority of cell types in the brain
in the context of an investing vasculature that is essential to meeting
the metabolic demands of the early expanding neuroepithelium.
Concomitant with the cellular expansion at the ventricular zones, the
vasculature invades from the perineural plexus at the pial surface to
establish a secondary plexus that provides a source for additional
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study tracking the expression of a series of transcription factors that
tightly control vascular investment indicated that the telencephalon
was vascularized in a ventral to dorsal and lateral to medial fashion,
suggesting that vascular investment is just as stringently regulated
as neural epithelial expansion (Vasudevan et al., 2008). A theme of
molecular and cellular interdependence is beginning to emerge
regarding development of the neural and vascular systems (reviewed
in D'Amore and Ng, 2002; Darland and D'Amore, 2001; Greenberg and
Jin, 2005; Ruiz de Almodovar et al., 2009; Shima and Mailhos, 2000).
One important factor that has been identiﬁed for its potential dual
role in the vascular and nervous systems is vascular endothelial
growth factor (VEGF), a member of a closely-related family of proteins
(VEGF A, B, C, D, E and placental growth factor) (Gale and
Yancopoulos, 1999; Neufeld et al., 1999). Here we focus on VEGF-A,
hereafter referred to as VEGF, and its role in early forebrain devel-
opment. Genetic ablation in mice of VEGF or its primary signaling
receptor, VEGFR2 (Flk-1/KDR), resulted in early embryonic (E)
lethality (E9 to E10) with phenotypes in both vascular and neuronal
lineages (Carmeliet et al., 1996; Ferrara et al., 1996; Shalaby et al.,
1995). VEGFR2 is expressed throughout the CNS vasculature (Ayadi
et al., 2001; Yamaguchi et al., 1993), but on close inspection of
these reported results in public database images (EMAGE), VEGFR2
is also present in the forebrain neuroepithelium (EMAGE:882;
EMAGE:5807) (Richardson et al., 2009). VEGF is expressed as several
isoforms that are generated by alternative splicing of a single gene
(Ruiz de Almodovar et al., 2009; Shima et al., 1996). The isoforms
differ in their size and in their ability to bind to heparan sulfate
proteoglycans on the cell surface and associated with the extracellular
matrix (Ferrara, 1999; Houck et al., 1992). The mouse gene encodes
three VEGF isoforms that are differentially expressed during devel-
opment and in different organ systems. VEGF expression in the late
developing brain is comprised of ~55–75% VEGF164 and ~20–50%
VEGF120; VEGF188 levels are virtually undetectable from E13.5
through to adult, although regional differences in expression were
not investigated (Ng et al., 2001).
While VEGF has been shown to be required for vascular devel-
opment, increasing evidence indicates that VEGF plays a direct role in
nervous system development (reviewed in (Rosenstein et al., 2010).
CNS expression of VEGFR2 (Flk-1/KDR) was ﬁrst identiﬁed in retinal
progenitor cells (Yang and Cepko, 1996) and has since been shown to
promote neuronal survival and axon outgrowth in cultured peripheral
neurons in vitro (Sondell et al., 1999; Sondell et al., 2000), cortical
neurons in vitro and in vivo (Jin et al., 2002; Zhu et al., 2003) and
retinal photoreceptors in vitro and in vivo (Saint-Geniez et al., 2008).
Recently, expression of VEGF-B has been linked with stimulation of
neurogenesis in the adult hippocampus and forebrain (Sun et al.,
2006). Moreover, localized expression of VEGF was required for
peripheral sensory neurons to act as directional guides for arteriole
branching in the skin, although the source of VEGF, neural or glial, was
unclear in this study (Mukouyama et al., 2002). VEGF isoforms and
cognate receptors have been identiﬁed in a neural stem cell popu-
lation in the subventricular zone of neonatal pig and the expression
persists in primary cultures grown as neurospheres (Ara et al., 2010).
Examination of VEGF protein in human fetal CNS tissue has dem-
onstrated localized expression throughout the cortical ventricular
zones associated with the vasculature, neurons and glia (Sentilhes
et al., 2010; Virgintino et al., 2003). A recent study of the role of VEGF
in the cerebellum has provided evidence that the VEGF isoforms are
differentially expressed in the postnatal cerebellum and are directly
involved in granule cell migration mediated by Flk1/VEGFR2 (Ruiz de
Almodovar et al., 2010). Therefore, VEGF is uniquely situated to affect
both neural and vascular development. The goal of this study was to
investigate the role of VEGF isoforms in regulating neurogenesis in
the context of the neurovascular interactions that contribute to early
forebrain and cortical development.Materials and methods
Generation of mouse embryos and genotyping
The VEGF120mouse line has been previously described (Carmeliet
et al., 1999). The VEGF120 homozygous embryos were generated by
heterozygous crosses since the homozygous VEGF120 mice die at
birth (Carmeliet et al., 1999; Ng et al., 2001). The VEGF-lacZ mice, in
which LacZ with a nuclear localization signal has been introduced into
the 3′ region of the gene, (Miquerol et al., 1999) were generously
provided by Dr. Andras Nagy (Samuel Lunenfeld Research Institute,
Mount Sinai Hospital, Toronto, Canada) and are maintained with a
heterozygous to wild type cross. Time-pregnant mice (plug date, day
0.5) were used to generate embryos from E7.5, E9.5, and E11.5. Same-
stage embryonic mice from different litters were combined as study
sets to obtain sufﬁcient wild type and homozygous individuals for
statistical conﬁdence. The viability of VEGF120 mice relative to wild
type littermates was determined by analyzing genotype yields for
E9.5 and E11.5 embryonic time points. A total of 53 E9.5 embryos
from 9 litters derived from VEGF120 heterozygous crosses yielded a
roughly normal distribution of genotypes with 9 wild-type (18%),
28 heterozygous (54%), and 14 homozygous (27%) embryos. A similar
genotypic yield was obtained at E11.5 during neuroepithelial ex-
pansion. A total of 42 E11.5 embryos from 13 litters derived from
heterozygous crosses yielded 11 wild type (26%), 21 heterozygous
(50%), and 10 homozygous (24%) embryos. Genotypewas determined
using standard PCR of puriﬁed genomic DNA (from tail cuts) as
described in (Carmeliet et al., 1996; Carmeliet et al., 1999; Saint-
Geniez et al., 2006). All animal studies were conducted using NIH
recommended guidelines for the care and use of animals in research
and approved by the University of North Dakota Institutional Animal
Care and Use Committee (#0807-1c).Immunolabeling
Embryos were ﬁxed in buffered 3.7% paraformaldehyde and
gradient equilibrated to 30% sucrose. Cryosectioning of imbedded
tissue was done with a Leica HM550 cryostat. Immunolabeling was
conducted as previously described (Darland et al., 2003) with
modiﬁcations for sections. In brief, sections were blocked and
permeabilized in 3% donkey serum (Vector Laboratories, Burlingame,
CA), 0.1% Triton X-100, 1% bovine serum albumin (BSA) in phosphate-
buffered saline (PBS) 2–3 h at room temp (RT) or overnight at 4 °C.
The primary antibody incubation was 1 h at RT or overnight at 4 °C
overnight, optimized for each antibody to reduce background. The
Pax6 primary antibody was incubated in 1% non-fat milk in Tris-
buffered saline solution overnight at 4 °C following a previously
published method (Nomura et al., 1998). Negative controls were the
absence of primary antibody as well as isotype- and species-matched
immunoglobulin at concentrations matching the primary antibody.
Primary antibodies used were: PAX6 (1:2000 dilution of ascites) and
nestin (1: 50 dilution of culture supernatant, Development Studies
Hybridoma Bank, Iowa City, IA), phosphohistone H3 (PHH3, 1:200,
Upstate Biotechnology, Lake Placid, NY), and Tbr2 (1:300, Abcam,
Cambridge, MA). Griffonia simplicifolia lectin B4 conjugated to FITC
was used at 1:200 (Vector Laboratories). The ﬂuorochrome-coupled
secondary antibodies were incubated 1 h at RT (1:200 dilution of
cy3 or FITC conjugated secondary donkey or goat antibodies, Jackson
ImmunoResearch Laboratories, Inc., West Grove, PA). Nuclei were
labeled with DAPI (Sigma, St. Louis, MO). In cases where signal am-
pliﬁcation was required the VectaStain Elite kit (Vector Laboratories)
for detection of biotin conjugated-horseradish peroxidase (avidin/
biotin complex method) was used. Slides were permanently mounted
with Vectashield mounting medium with or without DAPI (Vector
Labs).
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Quantitative comparison of VEGF protein in developing CNS was
determined using the VEGF ELISA kit for mouse (R & D Systems,
Minneapolis, MN). Neural epithelial tissue was microdissected after a
butterﬂy ﬂat mount of E11.5 embryos and the forebrain and midbrain
regions separated. The tissue was triturated in lysis buffer (25 mM
Tris–HCl pH 7.6, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate,
0.1% SDS) containing a cocktail of protease and phosphatase inhibitors
(Sigma, St. Louis, MO) and passed through a 25-gauge needle to
disrupt cells and shred genomic DNA. Samples were stored at−80 °C
and non-soluble and membranous material separated from the lysed
material after a 10-minute centrifugation at 14,000 rpm. Total protein
was determined with RCDC-Protein Assay (BioRad Laboratories,
Hercules, CA) and 50 μg of total protein was loaded onto the assay
plate and compared with a VEGF standard curve, as recommended by
the manufacturer.Quantitative real-time PCR (qPCR)
To generate E7.5 to E11.5 series for RNA analysis, embryos from
timed-pregnant mice were saturated in RNALater (Applied Biosystems,
Austin, TX) at 4 °C and microdissected after at least 24 h. For the E7.5
samples, the anteriorneural ectodermof three E7.5 embryoswaspooled
to obtain sufﬁcient RNA for cDNA synthesis. The E9.5 embryo heads
were collected with the caudal cut made at the midbrain/hindbrain
junction. The E11.5 embryo heads were dissected at the anterior divide
between the forebrain andmidbrainusing thebifurcationof the cerebral
artery as the dividing line. Total RNA was puriﬁed with PicoPure™ RNA
Isolation (Applied Biosystems) and quantiﬁed with a Nanodrop
spectrophotometer. Two hundred microgram of total RNA was
converted to cDNA (GeneAmp kit, Applied Biosystems) and real-time
PCR quantiﬁcation of target genes was completed with SybrGreen
detection on a AB7300 Thermocycler. Primer pairs were designed for
each target gene and optimized using Primer Express Software (Applied
Biosystems). The mRNA FASTA sequences were taken from the Entrez
Gene website (http://www.ncbi.nlm.nih.gov/sites/entrez) and com-
pared against those found on Ensembl Mouse Gene Viewer (http://
www.ensembl.org/Mus_musculus/index.html). Primers were optimized
for a GC content of 45–50%, a base pair length of ~20, a melting
temperature of 60 °C, and an optimal amplicon size of 50–250 bp (see
Table 1). The amplicons were designed to cross intron/exon boundaries.
All primers were checked for minimal hairpins and dimerization using
Oligo Analyzer (Integrated DNA Technologies, Coralville, IA). Target
product was ampliﬁed from E9.5 wild-type neuroepithelium cDNA and
subcloned into TOPO-TA-Sequencing (Invitrogen). ClonedproductswereTable 1
qPCR primers, sequence-validated amplicon size, and accession number.
Target Primer Amplicon Accession #
VEGF120 For5′-GCCAGCACATAGGAGAGATGAGC-3′ 95 bp NM_001025250.2
Rev 5′-CGGCTTGTCACATTTTTCTGG-3′ NM_001025257.2
VEGF164 For5′-GCCAGCACATAGGAGAGATGAGC-3′ 97 bp NM_001025250.2
Rev 5′-CAAGGCTCACAGTGATTTTCTGG-3′ NM_009505.3
VEGF188 For5′-GCCAGCACATAGGAGAGATGAGC-3′ 171 bp NM_001025250.2
Rev 5′-AACAAGGCTCACAGTGAACGCT-3′
SSeCKs/Gravin For 5′-CCGAGAAGAGAAAGGAGCAA-3′ 147 bp NM 031185.3
Rev 5′-AAGGCAACTCCACCTTCTCA-3′
Pax6
(55a and 56)
For 5′-GCTTGGTGGTGTCTTTGTCA-3′ 131 bp NM_013627.3
Rev 5′-TCACACAACCGTTGGATACC-3′
Nestin For 5′-CTTTCCTGACCCCAAGCTGA-3′ 79 bp NM_016701.3
Rev 5′-TGAGGACAGGGAGCACAGATC-3′
PECAM For 5′-CCGGGAAGTACAAATGCACA-3′ 150 bp NM_008816.2
Rev 5′-AGGAACAATTGACCGTCACG-3′sequence validated using BigDye Terminator v3.1 Cycle Sequencing Kit
(Applied Biosystems) on an ABI Prism 3100 Genetic Analyzer. Sequence-
validated products were ampliﬁed off the plasmid, gel puriﬁed (Qiagen)
and quantiﬁed by nanodrop for use in generating the standard curve. The
analysis approachwas based on the previously published protocol (Rhen
et al., 2007) and protocols provided following accepted qPCR guidelines
(Bustin et al., 2009).
The qPCR cycling proﬁle was 2 min. at 50 °C, 10 min. at 95 °C, then
40 repeated cycles alternating 15 s. at 95 °Cwith 1 min at 60 °C. A ﬁnal
dissociation step was included to determine uniformity of product
melting temperature. Puriﬁed plasmid DNA product for each primer
pair was used to generate standard curves ranging from 2 ng to
2×10−21 (ag) and the inverse log was used to determine DNA con-
centration in cDNA array samples of wild-type and E9.5 VEGF isoform
mice-derived neuroepithelium. Efﬁciency values for each primer pair
were calculated from the slope of the Ct versus DNA concentration
curve for the standard using the equation, [log10 (−1/slope)]-1, and
ﬁnal concentrations adjusted accordingly. All samples were quantiﬁed
in parallel for 18S as a reference gene to allow for variations in cDNA
synthesis efﬁciency between reactions. All cDNA synthesis reactions
were quality control checked with standard reverse transcription PCR
using glyceraldehyde phosphate dehydrogenase primers prior to
being used in the qPCR reactions.Design-based stereology
We used design-based stereology as an unbiased means of
quantifying PHH3- or Tbr2-positive nuclei independent of size or
spatial distribution (Schmitz and Hof, 2005). Sections from three or
four ﬁxed, frozen brains each of E11.5 wild type or VEGF120 mice
were cut at 30 μm and collected with gelatin-coated slides (Fisher
Scientiﬁc). Air dried sections were immunolabeled for PHH3 or Tbr2
as described above with modiﬁcations for a biotinylated secondary
antibody (Goat anti-rabbit~biotin, 1:200; Jackson) and Vectastain
Elite ABC horseradish peroxidase staining according to the manufac-
turer's instructions. Immunolabeled sections were counterstained
with methyl green solution to label nuclei and permanently mounted
after standard alcohol dehydration series and xylene exposure
(Vectamount, Vector Labs). Positive and total nuclei were counted
using an Olympus BX51WI with motorized XYZ stage. Unbiased
quantiﬁcation of nuclei was conducted using the optional fractionator
workﬂow in StereoInvestigator 9.0 (MicroBrightﬁeld, Inc., Wiliston,
VT). For the PHH3 counting, the contour outlined the neuroepithelium
within 100 μm of the ventricular surface from the forebrain structure
to the anterior limit of the diencephalon. For the Tbr2 counting, the
contour outlined the same region of the forebrain, however the outer
limit of the tracing was taken to the epithelial border beneath the
pial vessel surface to ensure inclusion of all positive nuclei within the
counting area. Positive nuclei (or total nuclei) were counted in every
10th section in systematically-selected frames based on optical
dissector frames and grid sizes determined separately for each
counting paradigm to ensure that the coefﬁcient of error was
less than 0.1 (10%); details for each are included in the ﬁgure legends.
The total numbers were estimated with the optical fractionator
formula (N=1/ssf.1/asf.1/hsf.ΣQ-) where ssf = section sampling
fraction (10), asf = area sampling fraction (area sampled/total area),
hsf = height sampling fraction (counting frame height/30 μm), and
ΣQ- (total particle count). Neuroepithelial volume was measured
based on the total tracing area, the actual z-plane measured section
thickness (accounting for tissue shrinkage), and the section interval.
For the mitotic spindle counts, a subset of the PHH3-positive nuclei
in the anterolateral loop of the telencephalon (bilateral) were counted
and mitotic spindles identiﬁed and counted relative to their
position in relation to the ventricular zone surface (parallel or
vertical/oblique).
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All statistical analyses were completed using GraphPad Prism 4.0c
for Macintosh (GraphPad Software, Inc., LaJolla, CA). An F test was
used to determine whether the population variances were statistically
different or not. Populationswith equal variance were analyzedwith a
two-tailed, unpaired t test with Welch's correction. Populations with
unequal variance were analyzed with a Mann–Whitney test. P values
are indicated in the ﬁgure legends or on the graph, but signiﬁcance
was determined with α value set to 0.05. Any data transformations
(e.g. natural log of ratios) are indicated in the legends. Because of the
small sample size, data shown are the mean +/− the standard error
of the mean with the n for each sample set indicated in the legend.
All embryo data shown were collected from multiple litters to gain
sufﬁcient numbers for the assay and to provide as representative a
population as possible for comparison.
Microarray and differential gene expression analysis
Microdissected forebrains from E9.5 embryos were collected and
total RNA puriﬁed as described above. Samples were submitted to
Genome Explorations Inc. (Memphis, TN) for further processing and
analysis. The RNA concentrationwas determined from the OD260/280
ratio and quality determined by capillary electrophoresis on the RNA
6000 Nano Lab-on-a-Chip kit and the Bioanalyzer 2100 (Agilent
Technologies, Santa Clara, CA) as per the manufacturers instructions.
Following fragmentation, 15 ug of biotinylated cRNA were hybridized
for 16 h at 45 °C on GeneChip 430.2 array (Affymetrix; GPL1261).
GeneChips were washed and stainedwith streptavidin-phycoerythrin
using the Affymetrix Fluidics Station 450, according to the manufac-
turer's recommended protocol. Hierarchical clustering analysis was
conducted using the PLIER values (Therneau and Ballman, 2008) for
genes that were differentially changed at least 1.5 fold with t-test
values≤0.05. The log2 transformed values were mean centered prior
to clustering analysis by the farthest neighbor method with Euclidean
distance and Pearson Correlation as the similarity metrics. The
Affymetrix annotation numbers were uploaded onto the Database
for Annotation, Visualization, and Integrated Discovery (DAVID) and
the enriched clusters identiﬁed with the mouse genome as the
population background (Huang et al., 2009a; Huang et al., 2009b). The
enrichment score reﬂects the geometric mean of all the enrichment
values for each gene in a given cluster. The Expression Analysis
Systematic Explorer (EASE) score (p value) is determined from a
modiﬁed Fisher's exact test (Hosack et al., 2003). It reﬂects the
signiﬁcance of the enrichment score as a representation of a func-
tional gene group relative to the expected representation based on
the population background. The Benjamini value corrects for false
positives in the enrichment p values with high stringency settings
used throughout.
Results
VEGF expression
The spatial and temporal pattern of VEGF ligand expression with
respect to neurogenesis was determined before evaluating any pos-
sible regulatory role in developmental neurogenesis. The develop-
mental window of E9.5 to E11.5 in mouse represents a period of rapid
expansion of the neuroepithelium, and vascular investment of the
CNS from the perineural plexus occurs in concert, with a temporal
delay in the forebrain (reviewed in Bär, 1980; Göetz and Huttner,
2005; Vasudevan et al., 2008). Early in situ hybridization studies
demonstrated signal for VEGFmRNA in the forebrain at E10.5 (Ferrara
et al., 1996), E12.5 (Dumont et al., 1995), and E17.5 (Breier et al.,
1995), although high-resolution images were not available from those
studies. In addition, the VEGF isoforms have been detected in brain byRNase protection assay at E13 (Ng et al., 2001) and in the postnatal
cerebellum (Ruiz de Almodovar et al., 2010). To determine if
VEGF was expressed speciﬁcally in the forebrain neuroepithelium,
we examined mice expressing the lacZ gene under control of the
endogenous VEGF promoter and containing a nuclear localization
signal (Miquerol et al., 1999). Mice at E9.5 were examined when
the perineural vascular plexus has formed over the neuroepithelium,
but vascular invasion into the forebrain has not fully initiated
(Figs. 1, A–C). Positive nuclei were present throughout the neuroe-
pithelium of the developing mouse brain. Quantiﬁcation of the three
major VEGF isoforms via qPCR from E7.5, E9.5, and E11.5 (Fig. 1D)
revealed that the VEGF isoform distribution changed proportionally
over time and was similar by E11.5 to the distribution previously
reported for whole brain at E13 (Ng et al., 2001) and the postnatal
cerebellum (Ruiz de Almodovar et al., 2010).Neuroepithelial development in mice lacking VEGF164
In order to test the hypothesis that VEGF regulates neuroepithelial
development, we used a mouse model system of disrupted VEGF
isoform expression, the VEGF120 mice. These mice express only a
single isoform of VEGF, VEGF120, and display abnormalities in the
cardiopulmonary system (Carmeliet et al., 1996, 1999; Ng et al.,
2001), the retina (Stalmans et al., 2002), and the granule cells of the
cerebellum (Ruiz de Almodovar et al., 2010). These mice lack the
predominant brain isoform VEGF164 as well as VEGF188, and express
only the diffusible VEGF120 protein, generally displaying early post-
natal lethality. To quantify the vascular investment in the VEGF120
mice, we examined expression levels for two genes associated with
angiogenesis, platelet endothelial cell adhesion molecule (PECAM)
and Src-suppressed C kinase substrate protein (SSeCKS). PECAM is
expressed in endothelial cells (EC) and concentrated at the junctions
between EC (reviewed in (Woodﬁn et al., 2007). Expression of SSeCKs
has been associated with angiogenesis and blood brain barrier
formation in early CNS development (Lee et al., 2003) and reviewed
in (Lee et al., 2009). Comparative mRNAwas quantiﬁed at E9.5, a time
point just prior to initiation of vascular ingrowth into the forebrain
neuroepithelium. The qPCR analysis showed a 33.3% reduction in
mean PECAM levels in the VEGF120 versus wild typemice. In contrast,
SSeCKs levels increased by 90% in the VEGF120 animals (Fig. 2A).
RNase protection has demonstrated that total VEGF mRNA levels are
equivalent in the VEGF120 mice relative to wild type (Carmeliet et al.,
1999) and we wanted to conﬁrm this at the protein level in the early
forebrain. Therefore, we measured levels of total VEGF protein using
the VEGFmouse ELISA (Fig. 2B). VEGF protein levels in E11.5 forebrain
neuroepithelium were not statistically different between VEGF120
and wild type samples (p=0.32).
We then examined the forebrain vasculature during early neuro-
epithelial expansion at E11.5 (Fig. 2C) and compared the patterns
of expression of inhibitor of DNA binding-1 (ID1) and nerve-glial
antigen 2 (NG2) in E11.5 wild-type and VEGF120mice (Fig. 2C). ID1 is
a transcription factor whose expression and nuclear localization are
associated with immature and dividing cells, most notably in EC
(reviewed in (Benezra et al., 2001; Ruzinova and Benezra, 2003). ID1-
positive cells (red) that co-labeled for G. simplicifolia lectin (green)
were observed in both pial vessels as well as vessels investing the
neuroepithelium, and were particularly prominent in pial vessels
of the VEGF120 mice. NG2-positive pericytes were associated with
vessels in wild type and VEGF120 neuroepithelium, but the pericyte
processes appeared less elaborate in the VEGF120 mice (Fig. 2C,
bottom panels). We further examined vascular investment two days
later (Fig. 2D) and observed that blood vessels in the wild type
forebrain were well developed and the lateral plexi formed through-
out the expanding neuroepithelium at E13.5 (Fig. 2D, left panel). In
contrast, the VEGF120 mice had compromised vascular investment
Fig. 1. VEGF expression in developing neuroepithelial cells. (A–D) VEGF-lacZ embryos (E9.5) were stained for ß-galactosidase (ß-gal) activity, imbedded in parafﬁn, sectioned in the
saggital plane along the midline, and counterstained with eosin. Formation of the secondary vesicles derived from the forebrain (F), midbrain (M) and hindbrain (H) are identiﬁed.
The ﬁrst brachial arch mesoderm (BA) is indicated for anatomic reference. The ß-gal gene product is targeted to the nucleus (Miquerol et al., 1999), so all VEGF-expressing cells have
blue nuclei. Blue nuclei are detected throughout the neuroepithelium. The boxed areas in A are shown in higher magniﬁcation in B (solid line) and C (dashed line). Arrows indicate
positive nuclei in the neuroepithelium and arrowheads indicate positive cells at the pial surface. The scale bars are 200 μm (A) and 50 μm (B–C). (D) Quantitative real-time PCR
(qPCR) analysis of the VEGF isoforms, VEGF120, VEGF164, and VEGF188 is graphed as a proportion of the total VEGF mRNA produced for isolated neuroepithelium from E7.5, E9.5
and E11.5 wild-type mice. Data are from 9 to 11 embryos from 3 to 5 litters, analyzed at each time point. The mean and standard error of the mean are graphed based on values
determined by comparison to an isoform-speciﬁc standard curve run in parallel.
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right panel).
Comparison of gene expression in wild type and VEGF120 neuroepithelium
Since neural stem cell proliferation at the ventricular surface and
in the basal progenitor population is the key to successful lamination
of the cortex, we examined in parallel the effect of expressing only the
diffusible VEGF120 isoform on the pattern of proliferating cells. The
phosphorylated form of histone H3 (PHH3) is normally associated
with M-phase mitotic cells, although detection has ranged as widely
as late G2 to the ﬁnal stages of anaphase (Hendzel et al., 1997; Nasr
and El-Zammar, 2008). PHH3 immunolabeling revealed numerous
positive nuclei present along the ventricular zone in the wild type
mice (Fig. 2D, left panel). PHH3-positive cells were detected in the
VEGF120mice aswell, however themitotic cells were clustered rather
than spaced in a continuous line along the ventricular zone (Fig. 2D,
right panel).
Since we observed differences in vascularization and proliferation
pattern in the VEGF120 neuroepithelium from E9.5 to E13.5, we
wanted to conduct a genome-wide survey of transcript expression
in the VEGF120 mice prior to the period of rapid expansion at E11.5.
We speculated that any changes in forebrain gene expression at E9.5would establish the conditions for subsequent changes in prolifera-
tion and neural stem cells at E11.5. Therefore, we used the Affymetrix
gene chip platform to compare gene expression proﬁles at E9.5
for wild type and VEGF120 embryos (Fig. 3). We puriﬁed total RNA
from microdissected wild type and VEGF120 forebrain (Fig. 3A) and
had four samples of each genotype processed and hybridized to the
Affymetric 430.2 mouse gene chip array (Genome Explorations). Of
the approximately 28,000 genes represented on 45,000 sites on the
chip, 21,000 sites hybridized consistently across all four replicates.
Based on ﬁltration criteria of a≥1.5 fold change in expression with an
unpaired t test p value of ≤0.05 we identiﬁed 329 genes that were
differentially expressed (Fig. 3B). Cluster analysis of all eight samples
showed grouping by genotype, reﬂecting consistent gene expression
changes across litters (Fig. 3C).
We next utilized the DAVID functional annotation database to
identify gene groups enriched among the 329 differentially expressed
genes relative to themouse genome. Using the high stringency setting
for functional annotation clustering, we identiﬁed two major clusters
of genes with enrichment scores of 3.3, the egf-like domain (Table 2)
and the negative regulation of gene expression (Table 3) functional
groups. We took particular note of the delta-like 1 homolog (Delta)
and jagged 2, notch signaling ligands that are both increased in
VEGF120 animals in the gene array, 1.78- and 1.5-fold, respectively
Fig. 2. Disruption of VEGF isoform expression affects normal vessel formation in developing neuroepithelium. (A) Determination of relative mRNA expression was quantiﬁed by
qPCR for PECAM and SSeCKs/Gravin in E9.5 neuroepithelium from wild type and VEGF120 (120/120) mice. Data are from seven embryos collected from at least three litters. Two-
way ANOVA analysis of expression indicated that there was a signiﬁcant source of variation between the genes (45.87%; pb0.0001) with genotype accounting for 5.73% of the
variation (p=0.10); the signiﬁcance from Bonferroni's post-hoc tests are indicated in the ﬁgure. (B) VEGF protein levels in 50 μg total protein were measured in forebrain lysates
from E11.5 neuroepithelium using a standard mouse ELISA assay. Data are from seven embryos collected from three litters. Both populations had a normal distribution, but unequal
variance (F test, p=0.003). While the VEGF120 mean value was 20% higher than the wild type mean, the difference was not statistically signiﬁcant (Mann-Whitney test, p=0.32).
(C) Immunolabeling for Id1 (red) or NG2 (red) in combination with G. simplicifolia lectin~FITC (green) is shown for sections from E11.5 wild type and VEGF120 littermates.
Id1-positive endothelial cells were present in the neuroepithelial vessels (arrows) and in the pial vessels in both wild type (left top panel) and VEGF120 (middle top panel). Lectin
co-labeling highlighted the differences observed in vessel formation between wild type and VEGF120 mice. Rabbit IgG as a negative control is shown for comparison (right top
panel). Scale is 25 μm in the top and bottom panels. NG2-positive pericytes process (arrowheads) with associated lectin-labeled vessels are shown in the bottom panels for wild
type (left bottom panel) and VEGF120 (right bottom panel). (D) Immunolabeling for phosphohistone H3 (PHH3) as a marker of mitotic cells is shown for E13.5 dorsolateral
telencephalon (Tn) in combination with lectin~FITC. The anterior loop of the forebrain is shown with arrows indicating PHH3-positive cells adjacent to investing blood vessels
(green, arrowheads). The scale bar is 200 μm.
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Fig. 3. Differential gene expression in wild type and VEGF120 mice at E9.5.
(A) Representative image of an E9.5 embryo with the microdissected region traced in red.
The isolated tissue included the forebrain regionwith the lateral telencephalon pouches and
a caudal border of the ingressing diencephalon. (B)Venn diagram illustrating thenumber of
sites detected on the Affymetrix 430.2 mouse chip comparing four each of wild type (WT,
blue) and VEGF120 (V120, pink) samples with the region of common expression indicated
as present (purple). The number of differentially expressed genes increased in wild type
(191↑) and increased inVEGF120 (138↑) are basedon≥1.5 difference and anunpaired t test
p value of ≤0.05. (C) The PLIER signals for the differentially expressed genes were
transformed to the base 2 log and rowmean centered. The heat map shownwas generated
via unsupervised (unbranched) hierarchical clustering of the samples with relative Log2
signal intensity indicated below. The dendrogram on the right indicates the distance
relationships between the clustered samples while the dendrogram above indicates the
relationships among the genes. GEO/NCBI submission link for microarray data and
additional supporting analysis has been accepted and is: GSE30767.
Table 3
Fold changes in expression of cluster 2 enriched genes are listed for “negative regulation
of gene expression” with an enrichment score of 3.26 (p=0.00027; Benjamini
score=0.046).
AFFYMETRIX
3PRIME_IVT_ID
Gene name Fold change
↑ OR ↓ IN
VEGF120
t test
p value
in array
1459916_at Paired box gene 5 2.13↓ 0.003
1421749_at lin-28 homolog 1.78↓ 0.0072
1434572_at Histone deacetylase 9 1.69↓ 0.0006
1415996_at Thioredoxin interacting protein 1.65↓ 0.017
1421515_at Nuclear receptor subfamily 6, group A,
member 1
1.61↓ 0.031
1441743_at Paired box gene 3 1.54↓ 0.012
1438802_at Forkhead box P1 1.88↑ 0.033
1435022_at ALX homeobox 1 1.83↑ 0.039
1449470_at Distal-less homeobox 1 1.70↑ 0.0034
1419437_at Single-minded homolog 2 1.66↑ 0.033
1440004_at Suppressor of fused homolog 1.63↑ 0.0002
1420020_at Suppressor of zeste 12 homolog 1.58↑ 0.045
1447564_x_at Piwi-like homolog 4 (Drosophila) 1.56↑ 0.042
1424667_a_at Cut-like homeobox 1 1.54↑ 0.035
1417302_at REST corepressor 2 1.51↑ 0.028
1425528_at Paired related homeobox 1 1.51↑ 0.020
Table 2
Fold changes in expression of cluster 1 enriched genes are listed for “egf-like domain”
with an enrichment score of 3.33 (p=0.00013; Benjamini score=0.031).
AFFYMETRIX
3PRIME_IVT_ID
Gene name (functional domain) Fold change
↑ OR ↓ IN VEGF120
t test
p value
in array
1447352_at A disintegrin and
metallopeptidase domain 8
2.24↓ 0.028
1421134_at Amphiregulin 2.83↓ 0.003
1427393_at Coagulation factor IX 2.99↓ 0.006
1451759_at Mannan-binding lectin serine
peptidase 2
1.89↓ 0.037
1440173_x_at Selectin, platelet 1.88↓ 0.044
1455978_a_at Matrilin 2 1.73↓ 0.032
1443131_at Low density lipoprotein-related
protein 1B (deleted in tumors)
3.23↑ 0.008
1455499_at Neurexin II 2.87↑ 0.026
1457123_at Neuregulin 4 2.01↑ 0.031
1447586_at Versican 1.87↑ 0.0001
1449939_s_at Delta-like 1 homolog
(Drosophila)
1.78↑ 0.032
1426431_at Jagged 2 1.50↑ 0.037
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whose expression has been linked to control of fate choice in neural
precursors via Notch-Delta lateral inhibition (Kawaguchi et al., 2008).
The Dll1 gene expression is elevated 1.7-fold in the array. We also
noted enrichment of two genes, upregulated in the array, that have
been linked to neural precursor differentiation and cell fate choice
in the cortex. These include forkhead box P1 (Foxp1), that is normally
expressed primarily cortical layers 3–5 as lamination proceeds
(Ferland et al., 2003), and Cut-like homeobox 1 (Cux-1) that is asso-
ciated with upper cortical layers (Nieto et al., 2004) and reelin-
positive interneurons (Cubelos et al., 2008). They are upregulated
1.88- and 1.54-fold in the array. While only a small number of genes
are differentially expressed in the presence of VEGF120 alone (refer to
Fig. 3B), the expression changes provide a transcriptional background
at E9.5 that precedes and informs the critical neuroepithelial ex-
pansion at E11.5.
Because a subset of the differentially expressed genes identiﬁed by
the functional enrichment DAVID analysis had the potential to impact
notch signaling or were associated with neural differentiation, we
wanted to examine the affects of the altered transcription background
on the neural stem populations at E11.5. We ﬁrst examined PHH3
labeling at E11.5 when early neural stem cell proliferation is at a peak.
We observed PHH3-positive nuclei in the ventricular zone in the wildtype as well as a secondary population of proliferating cells in the
subventricular zone (Fig. 4A). In contrast, in VEGF120 mice there
was a much more restricted pattern of PHH3-labeled nuclei with
the majority of mitotic proﬁles restricted to the apical surface of
the ventricular zone. To more clearly assess the differences in PHH3
labeling, we used design-based stereology to quantify the number of
PHH3-positive cells in VEGF120 isoform mice compared to wild type
(Figs. 4, B–D). We observed a statistically signiﬁcant drop in the
number of PHH3-positive cells and the neuroepithelial volume in
VEGF120 mice relative to wild type.
Because of the altered neuroepithelial proliferation pattern and
the shift in gene expression proﬁle in mice with the disrupted VEGF
isoform proﬁle, we speculated that there would be a direct impact on
the neural stem cell populations. Therefore, we next analyzed Pax6, a
transcription factor found in actively proliferating neural stem cells
and radial glia (Götz et al., 1998), and nestin, a cytoskeletal protein
that has been used as a marker for neural stem cells (reviewed in
Gilyarov, 2008). Examination of E11.5 mice revealed a Pax6-positive
population of cells in the wild type telencephalon near the anterior
loop encompassing the majority of the neuroepithelium with a Pax6-
negative band of cells adjacent to the pial surface (Fig. 5A). In
Fig. 4. Expression of only VEGF120 alters the pattern of proliferating cells in the developing neuroepithelium. (A) Immunolabeling for in E11.5 neuroepithelium from wild type
(left panels) and VEGF120 mice (right panels) is shown with the ventricular zone at the top and the pial surface at the bottom. PHH3-positive cells (red) are localized to the
ventricular zone and immediately below. The full area of the neuroepithelium is highlighted with DAPI-positive nuclei (blue) in the two-channel overlay. The white arrows indicate
representative PHH3-positive cells. The white arrowheads indicate representative cells that have completed cell division but have retained the characteristic punctate labeling when
a portion of the nucleosome still has the antibody epitope available for binding. The scale bar equals 25 μm. This experiment was repeated four timeswith similar results. The samples
shown are from embryonic littermates. (B) Low power images are shown for PHH3 immunolabeling in the lateral telencephalon (Tn) and the ganglionic eminence (Ge) in wild type
and VEGF120 E11.5 embryos. Arrows indicate areas of DAB reaction product (brown) localized to the ventricular surface with nuclei counterstainedwithmethyl green. Design-based
stereology and unbiased systematic random sampling were used to quantify the number of PHH3-positive cells (C) and the total neuroepithelial volume (D). The optical dissector
frame was 75×75 μm and the counting grid was set at 150×200 μmwith a counting frame height of 20 μm and 2 μm guard zones on either side. The mean and standard error of the
mean are shown for three animals of each genotype. The variances were not signiﬁcantly different and the p values from an unpaired t test are indicated in the graph.
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17D.C. Darland et al. / Developmental Biology 358 (2011) 9–22VEGF120 mice the width of the band of Pax6-positive neuroepithelial
cells appeared reduced with few Pax6-negative cells at the pial
surface. Co-labeling for laminin, which localized to the basement
membrane at the pial surface and in blood vessels, further highlights
the differential distribution of Pax6-positive cells between wild type
and VEGF120 mice. Nestin immunolabeling had a radial pattern in
the cytoskeleton of cells throughout the expanding neuroepithelium
from the ventricular to the pial surface (Fig. 5B). Nestin-positive cells
were present in the VEGF120 mice, although the radial pattern was
disrupted and punctate labeling was observed at the pial surface
where the glial end feet normally embed in the basement membrane
(Haubst et al., 2006).
In order to quantify the differences observed with the Pax6 and
nestin immunolabeling, levels of gene expression in E9.5 wild type
and VEGF120 neuroepithelium were measured by qPCR. As expected,
Pax6 and nestin mRNA were detected in wild type samples (Fig. 5C).
Levels of nestin and Pax6 in VEGF120 samples were signiﬁcantly
reduced when compared to the wild type samples; nestin was
reduced 53% and Pax6 was reduced 67%. It is important to note that
these differences were quantiﬁed at E9.5, a time when little to no
vascular investment of the forebrain neuroepithelium has occurred,
indicating that the differences are due to a direct effect of VEGF120, orFig. 5. Disruption of VEGF isoform expression alters Pax6 and nestin expression in E11.
neuroepithelium with the ventricular surface at the top and the pial surface at the bottom. (A
VEGF120 mice and DAPI nuclear stain reveals the cellular population of the neuroepithelium
the pial surface and associated with blood vessels. (B) The pattern of nestin ﬁlament stainin
the pial surface of VEGF120 embryos. Scale bar is 50 μm in A and 25 μm in B. (C) The qPC
although statistical analyses were conducted separately. RNA from E9.5 wild type and VEGF
least three litters. Unpaired t test withWelch's correction showed that Pax6 expression was r
was not signiﬁcantly different (p=0.133). Analysis of nestin expression showed a 53% decthe absence of VEGF164 and VEGF188, on the neural stem cell
populations.
Since the neural stem cell population of the VEGF120 mice was
disrupted, we next determined the early consequence for the differen-
tiation process. We examined expression of the T-box transcription
factor 2 (Tbr2), that has been identiﬁed as a transcriptional marker of
intermediate progenitor cells in the developing cortex (reviewed in
(Hevner et al., 2006). Tbr2 is normally expressed as stem cells divide
andmove away from the ventricular zone, but remain in a mitotic state
and mark the basal progenitor population of the subventricular zone
(Ciruna and Rossant, 1999; Kimura et al., 1999; Sessa et al., 2008). In the
wild type mice at E11.5 a layer of Tbr2-positive cells was observed
approximately midway between the ventricular and pial surfaces
(Fig. 6A). Although a Tbr2-positive population was also detected in the
VEGF120 mice, the cells were tightly clustered at the primitive cortical
plate at the pial surface in a pattern distinct from the wild type.
We next quantiﬁed the number of Tbr2-positive cells in the
E11.5 neuroepithelium to determine the changes in the intermediate
progenitor population as a result of altered VEGF isoform proﬁle.
Because we saw a decrease in the number of PHH3-positive cells in
the VEGF120 mice relative to the wild type, we anticipated seeing a
corresponding reduction in the number of Tbr2-positive cells. To our5 neuroepithelium. Immunolabeling for (A) Pax6 and (B) nestin is shown in E11.5
) The extent of the Pax6-positive domain is indicated by white arrows for wild type and
. Labeling for laminin (Lam) in A identiﬁes the limiting basement membrane adjacent to
g is shown with the white arrows indicating the region of globular nestin expression at
R for nestin (white bars) and Pax6 (black bars) are graphed together for comparison,
120 (120/120) neuroepithelium are shown with ﬁve or six samples combined from at
educed by 67% in the VEGF120 compared to wild type, although the observed difference
rease (p=0.049) in the VEGF120 samples compared to wild type.
Fig. 5 (continued).
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between wild type and VEGF120 (Fig. 6B), although the total volume
differences measured in this experiment were consistent with that
observed for the PHH3-based total volume measurements (Fig. 6C).
We compared the Tbr2 counts to the PHH3 counts (refer to Fig. 4)
and expressed these as a ratio (Fig. 6D). There was an increase in
the number of Tbr2-positive nuclei relative to PHH3-positive nuclei
in the VEGF120 mice compared to wild type. In order to assess
the mechanism for this apparent shift in the neural stem cell versus
intermediate progenitor population, we next quantiﬁed the number
of total mitotic proﬁles and their position relative to the ventricular
zone surface (Fig. 6E). In the PHH3-positive population of cells of the
anterolateral telencephalon, we determined that wild type and
VEGF120 mice had similar numbers of mitotic spindle proﬁles that
resulted in one daughter cell losing contact with the ventricular zone
(90˚ angle or oblique angle). In contrast, the VEGF120 mice had
signiﬁcantly fewer mitotic spindles where both daughter cells would
retain contact with the ventricular surface. Taken together, these
results suggest that the VEGF120 supports the intermediate progen-
itor population at the expense of neural stem cell proliferation.
Discussion
Our results provide evidence for a role for VEGF in early neu-
roepithelial development in the mammalian cortex. VEGF is expressedtemporally and spatially in a manner that is consistent with an effect on
both the neural and vascular components of early forebrain expansion
during theE9.5 toE11.5developmentalwindow. The availability of a line
of mice that express only VEGF120 has allowed for direct testing of the
hypothesis that VEGF164 is required for normal neuroepithelial
development. VEGF120 mice, which lack the longer, matrix- and
heparan sulfate proteoglycan-binding VEGF isoforms (VEGF164 and
VEGF188), displayed reduced neuroepithelial proliferation. Several key
genes that are involved in notch signaling (Delta, jagged 2, Dll1), or are
associated with neural differentiation (FoxP1, Cux1), were differentially
expressed in a microarray analysis of the E9.5 VEGF120 mice. The
impact of these changes in gene expression manifested at E11.5 as
signiﬁcant alterations in the neuroepithelium. Levels of nestin
mRNA were signiﬁcantly reduced and there was a restricted area of
immunolabeling for Pax6- and nestin-positive stem cell populations
relative to wild type controls. However, the number of Tbr2-positive
basal progenitors that form a secondary proliferative zone in the
developing cortex was unchanged in the VEGF120 mice at E11.5.
Moreover, therewas a corresponding reduction in the number ofmitotic
spindleproﬁles thatwould result in bothdaughter cells retainingcontact
with the ventricular zone and sustaining an active precursor population.
Taken together, these data indicate that while VEGF120 alone is able
to mediate some of the roles of VEGF in the early neuroepithelium,
VEGF164 and VEGF188 appear to be required to sustain the neural
precursor population prior to early cortical lamination.
Fig. 6. Tbr2-positive intermediate progenitors are preferentially supported relative to neural stem cells in VEGF120 mice. (A) Immunolabeling for Tbr2 is shown in E11.5
neuroepithelium from the anterior primitive telencephalon (Tn) with the lateral loop shown in low magniﬁcation on the left for wild type and VEGF120 (scale bar is 200 μm). The
center panel shows Tbr2-immunopositive nuclei (red) with the ventricular surface at the top and the pial surface at the bottom. Positive cells highlight a secondary population of
proliferating precursors intermediate between the ventricular zone and the pial surface in wild-type animals. A restricted band of Tbr2-positive cells is identiﬁed in the VEGF120
mice. The same area in overlay with DAPI stained nuclei (blue) is show on the right for comparison (scale bar is 50 μm). The samples shown are from littermates and the
immunolabeling was repeated three times with similar results. Design-based stereological quantiﬁcation of Tbr2-positive cells (B) and neuroepithelial volume (C) in wild type
versus VEGF120 mice at E11.5. The optical dissector frame was 75×75 μm and the counting grid was set at 80×80 μmwith a counting frame height of 18 μm and 2 μm guard zones
on either side. Values shown are mean and SEM for three samples counted with the investigator masked to genotype. The p values for unpaired t tests are shown in the ﬁgures. The
number of Tbr2-positive cells was then related to the number of PHH3-positive cells in matched animals and expressed as a ratio (D). The ratios were transformed to the natural log
and signiﬁcance tested with an unpaired t test; p values are indicated in the ﬁgure. (E) The number of mitotic spindles in a subset of PHH3-positive cells in the anterolateral
telencephalon were quantiﬁed as parallel or oblique/perpendicular to the ventricular surface reﬂecting the orientation of the daughter cells after division. The optical dissector frame
was 40×40 μm and the counting grid was set at 80×80 μm with a counting frame height of 18 μm and 2 μm guard zones on either side. The mean and SEM for three embryos is
graphed and signiﬁcance tested with an unpaired t test; p values are indicated in the ﬁgure.
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effect of VEGF on developing neural stem cells is the difﬁculty in
determining whether an observed change is due to a direct effect ofVEGF or due to immature or insufﬁcient vascularization. The early
forebrain neuroepithelium, which gives rise to many of the anterior
brain structures, including the cortex, is vascularized from a neural
20 D.C. Darland et al. / Developmental Biology 358 (2011) 9–22plexus that invades the expanding neuroepithelium beginning at
approximately E9.5. Clear evidence indicates that even as little as a
two-fold deviation (increase or decrease) in VEGF levels will lead
to abnormal vascularization resulting in increased apoptosis and
reduced neuroepithelium (Haigh et al., 2003; Wada et al., 2006).
Furthermore, examination of vascularization of the hindbrain of
VEGF120 mouse from E10.5 to E13.5 revealed that the vessels in the
established vessel network have reduced branching and a larger,
distended lumen (Ruhrberg et al., 2002), although overall vascular
investment was unaltered. Consistent with these results, the few
initial vessels in the forebrain of the VEGF120 mice are grossly similar
to those in the wild type embryos, although there are dramatic
differences in telencephalic vascularization by E13.5. Thus, regional
differences in the timing of vascularization may account for the lack
of vessels at E11.5 since the telencephalon is not fully vascularized
until E13.5 (Bär, 1980; Vasudevan et al., 2008). Our results suggest
that VEGF120 alone is sufﬁcient to support survival of the forebrain
neuroepithelial cells, at least to the E11.5 stage where vascular
compromise is not yet a signiﬁcant factor. Studies using a nestin-
promoter driven system to control stem cell-speciﬁc changes in VEGF
expression levels resulted in signiﬁcant increases in apoptosis that
accompanied abnormal vascularization in neural tissues, speciﬁcally
late stage cortex and retina (Haigh et al., 2003). We do not observe
increased apoptosis or overtly abnormal vascularization in the
VEGF120 mice at E11.5 (Fig. 2 and data not shown), possibly due to
the fact that our mouse model represents a shift in isoform proﬁle
expression rather than a change in total VEGF protein levels that do
not impact vascularization signiﬁcantly until later in telencephalon
development.
One of the most revealing results of our investigations was the
functional enrichment of the notch pathway moderating genes and
the cortical neuron differentiation-associated genes in our microarray
analysis. The DAVID platform proved to be an invaluable tool for
mining genes in our microarray whose differential expression might
affect neural precursor populations. The notch signaling pathway
plays a variety of roles throughout all stages of development in a
variety of tissues, particularly the vascular system (Gridley, 2001) and
the CNS (Lathia et al., 2008). The genes present in the top two DAVID-
enriched clusters collectively reﬂect a series of transcriptional
changes that may be indicative of reduced notch signaling and
precocious differentiation. The Dll1 gene, which was upregulated in
the VEGF120 mice, has been shown to have differential effects on
neural progenitor populations in the telencephalon (Yun et al., 2002)
and depending on its expression level, can promote early neurogen-
esis (Kawaguchi et al., 2008) in the developing cortex. While all four
Notch genes (Notch 1–4) were detected in our array, they were
not differentially expressed (data not shown). However, the helix-
loop-helix transcription factor, single-minded homolog 2 (Sim2) was
upregulated in the VEGF120 mice and its expression has been shown
to be downregulated by notch signaling induced in MCF10A breast
cancer cells (Gustafson et al., 2009).
The possible downregulation of notch signaling would, indeed,
lead to precocious differentiation as has been previously reported
for several transgenic mouse models that result in disrupted notch-
delta signaling (reviewed in (Lathia et al., 2008). Moreover, a back-
ground of increased Dll1/Delta/jagged 2 suppressing notch signaling
at E9.5 correlates well with early increased expression of FoxP1 and
Cux1 that mark cortical layer formation (Cubelos et al., 2008; Ferland
et al., 2003; Nieto et al., 2004). We speculate that the marked change
in the neuroepithleium at E11.5 that affects neural progenitor
proliferation is the result of these early shifts in gene expression.
While we observed variation in the total Tbr2 protein levels by
western blot in E11.5 neuroepithelium (data not shown), there was
no difference in total cell number indicating that absence of VEGF164
and VEGF188 had no signiﬁcant impact on establishment of the
intermediate progenitor population. Analysis at later developmentalstages might reveal a greater impact of loss of VEGF164 and VEGF188
on the Tbr2 population or the post-mitotic Tbr1 population and its
cortical derivatives. However, it would be difﬁcult to interpret these
studies as the expanding neuroepithelium has a growing dependence
on vascularization that is increasingly compromised with further
development.
Our observations indicate that the full proﬁle of VEGF isoform
expression is essential for the establishment and differentiation of
the forebrain neuroepithelium and its vasculature. The reduction in
overall proliferation and in parallel mitotic spindle proﬁles, leading
daughter cells to maintain stem cell status via apical contact with
the ventricular surface, are consistent with an alteration in notch
signaling that is predicted by the microarray data. Under normal
circumstances, VEGF164 is the predominant isoform in the brain with
VEGF188 being expressed in only small amounts. Therefore, the
phenotype observed in the VEGF120 mice may be due to absence
of the predominant isoform, VEGF164, or due to the absence of any
locally-retained VEGF protein (VEGF164 or VEGF188). The VEGF164
isoformmay be required for full maintenance of the progenitor popu-
lation and the VEGF120 alone may be insufﬁcient to sustain normal
proliferation and survival. The idea of speciﬁc roles for individual
isoforms is not necessarily in contradiction to an integrated role for
the isoforms based on matrix association versus diffusion. Such an
isoform gradient model has been proposed previously for hindbrain
and retinal vascularization (Gerhardt et al., 2004; Ishida et al., 2003;
Ruhrberg et al., 2002). The gradient model would lead to the
hypothesis that the local retention of VEGF164 and VEGF188 may
act as a point source of VEGF at the pial surface while the diffusion of
VEGF164 and VEGF120 would establish a gradient to support neural
stem cell populations and guide migration of neuronal precursors
and post-mitotic neurons as the layered cortex forms. Our results
indicate that the absence of the locally-retained isoforms, VEGF164
and VEGF188, leads to reduced proliferation without impact on the
number of Tbr2-positive intermediate progenitors. These data con-
tribute to the growing evidence of the multi-faceted role that a
traditional “vascular” factor plays during CNS development, contrib-
uting to neurovascular development at many levels.
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